About Theragnostics
Theragnostics is a company based in Bracknell (United Kingdom) founded in 2015 was acquired by Ariceum Therapeutics in June 2023.. The company has 4 employees as of June 30, 2021. Theragnostics operates in a competitive market with competitors including Radionetics, Hinova Pharmaceuticals, Convergent Therapeutics, Nuage Therapeutics and Nymox Pharmaceutical, among others.
- Headquarter Bracknell, United Kingdom
- Employees 4 as on 30 Jun, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Theragnostics Limited
- Date of Incorporation 19 Jul, 2013
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$1.69 M (USD), Grant
May 16, 2017
-
Investors
HHS
& 1 more
-
Employee Count
4
as on Jun 30, 2021
-
Acquired by
Ariceum Therapeutics
(Jun 01, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Theragnostics
- Total Funding Total Funding
- Total Rounds 3
- Last Round Grant — $1.7M
-
First Round
First Round
(25 Sep 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2017 | Amount | Grant - Theragnostics | Valuation |
investors |
|
| Apr, 2017 | Amount | Grant - Theragnostics | Valuation |
investors |
|
| Sep, 2015 | Amount | Grant - Theragnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Theragnostics
Theragnostics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Ariceum Therapeutics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Developer of drugs for systemic targeted radiation therapy to treat cancer
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Theragnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Theragnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Theragnostics Comparisons
Competitors of Theragnostics
Theragnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Radionetics, Hinova Pharmaceuticals, Convergent Therapeutics, Nuage Therapeutics and Nymox Pharmaceutical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Peptide-targeted radiopharmaceuticals for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Develops small molecule based drug for multiple disease treatment
|
|
| domain | founded_year | HQ Location |
Cancer therapeutics are developed using dual-targeted radionuclide therapy.
|
|
| domain | founded_year | HQ Location |
Drugs are developed for intrinsically disordered protein targets.
|
|
| domain | founded_year | HQ Location |
Provides research and development of novel drugs and diagnostic products for the aging population
|
|
| domain | founded_year | HQ Location |
Translational glycobiology research on galectin-3 inhibitors is conducted.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Theragnostics
Frequently Asked Questions about Theragnostics
When was Theragnostics founded?
Theragnostics was founded in 2015.
Where is Theragnostics located?
Theragnostics is headquartered in Bracknell, United Kingdom. It is registered at Bracknell, England, United Kingdom.
How many employees does Theragnostics have?
As of Jun 30, 2021, the latest employee count at Theragnostics is 4.
What does Theragnostics do?
Theragnostics was founded in 2015 in Bracknell, United Kingdom, within the biotechnology sector. Diagnostic and therapeutic agents are developed and commercialized, with operations centered on oncology applications. A technology platform named Galli is employed to create PET Gallium-68 diagnostics and radionuclide therapies. The lead product, THG-001 (Ga-68 THP-PSMA), is advanced for prostate cancer detection and treatment, currently in phase 2 clinical trials.
Who are the top competitors of Theragnostics?
Theragnostics's top competitors include Radionetics, Nuage Therapeutics and Convergent Therapeutics.
Who are Theragnostics's investors?
Theragnostics has 2 investors. Key investors include HHS, and Ariceum Therapeutics.